You have read all your free articles, to continue reading subscribe to read the rest of this content.
Merck & Co has licensed its experimental cancer drug to AstraZeneca for a $50 million upfront fee. Under the terms of agreement Merck will also be eligible to receive future payments related to development and regulatory milestones as well as tiered royalties. The drug called MK-1775 is curreAlready a subscriber…
Janssen Pharmaceuticals has entered into a collaboration and license agreement with Bavarian Nordic to leverage their MVA-BN technology, jointly with Janssen's own AdVac technology, in the development and commercialization of a heterologous prime-boost vaccine for the treatment of HPV chronic infectAlready a subscriber Login You have read all your free…
The two companies brings Sectra CloudFlex, a cloud-based, comprehensive suite of breast imaging tools designed for low-volume mammography sites. The tools' modular functionality includes a clinical reporting platform, advanced speech recognition technology, a workflow portal and CRM system. This Already a subscriber Login You have read all your free articles,…
Karolinska Institutet and St. Erik Eye Hospital have entered into a collaboration with Novo Nordisk A/S to develop a new treatment for age-related macular degeneration. Novo Nordisk will provide support and SEK 48 million in funding to enable a phase 1 clinical trial where new retinal cells generAlready a subscriber…
